1-Bromo-4-(1,1-difluoroethyl)benzene

We are 1-Bromo-4-(1,1-difluoroethyl)benzene CAS:1000994-95-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-Bromo-4-(1,1-difluoroethyl)benzene
CAS.NO:1000994-95-5
Synonyms:1-Bromo-4-(1,1-difluoroethyl)benzene
4-(1,1-Difluoroethyl)phenyl bromide
Molecular Formula:C8H7BrF2
Molecular Weight:221.0419864
 
Physical and Chemical Properties:
Density:1.495
Boiling point:80-82ºC
Flash point:82ºC
Index of Refraction:1.503
 
Specification:
Appearance:Colorless to Yellow clear liquid
Assay(GC):≥98.0%
 
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediates of pharmaceutical

1-Bromo-4-(1,1-difluoroethyl)benzene


Related News: Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.1-bromo-10-fluorodecano CAS:334-61-2 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.Ethyl 2,4,5-trifluorobenzoylacetate In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.93777-26-5 Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.

Related Products
Product Name
delta-Valerolactone View Details
Thymidine 5′-Triphosphate Sodium Salt View Details
1-isothiocyanato-4-(trifluoromethoxy)benzene View Details
4,5-Diamino-1-(2-Hydroxy)Ethyl Pyrazole Sulfate manufacturer 2,4,6-TRICHLOROPHENYL ISOTHIOCYANATE manufacturer 2-Bromo-6-methoxypyridine manufacturer Portulaca oleracea, ext. manufacturer 2,6-di(propan-2-yl)aniline manufacturer